Agreed on this being an AA-design trial. I suppose they are going for leaving no stones unturned in proving the platform, which is good. An accelerated approval means the drug can go to the market after great phase 2 results, provided the company still runs a p3 trial on the side. If the results from the p3 trial do not meet endpoints, the drug will be taken off the market.
News 
Market Data 
Discover 
AI
